Aethlon Medical (AEMD) Market Capitalization (2010 - 2026)

Aethlon Medical (AEMD) has reported Market Capitalization for 17 consecutive years, with $315458.1 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 36.7% year-over-year to $315458.1; the trailing twelve-month figure through Jun 2026 stood at $315458.1 (down 36.7% YoY), and the FY2026 full-year result was $295187.9, down 66.98% from the prior year.
• Market Capitalization climbed to $315458.1 in Q2 2026 per AEMD's latest filing, from $295187.9 in the prior quarter.
• Across five years, Market Capitalization topped out at $4.5 million in Q1 2022 and bottomed at $295187.9 in Q1 2026.
• Historically, Market Capitalization has averaged $1.5 million across 5 years, with a median of $1.1 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Market Capitalization plunged 77.93% in 2022, then soared 111.54% in 2024.
• Over 5 years, Market Capitalization stood at $1.3 million in 2022, then declined by 10.11% to $1.1 million in 2023, then jumped by 111.54% to $2.4 million in 2024, then plunged by 77.59% to $539161.1 in 2025, then plunged by 41.49% to $315458.1 in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $315458.1, $295187.9, and $539161.1 for Q2 2026, Q1 2026, and Q4 2025 respectively.